1. Home
  2. EDSA vs NVFY Comparison

EDSA vs NVFY Comparison

Compare EDSA & NVFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • NVFY
  • Stock Information
  • Founded
  • EDSA 2015
  • NVFY 2003
  • Country
  • EDSA Canada
  • NVFY United States
  • Employees
  • EDSA N/A
  • NVFY N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • NVFY Home Furnishings
  • Sector
  • EDSA Health Care
  • NVFY Consumer Discretionary
  • Exchange
  • EDSA Nasdaq
  • NVFY Nasdaq
  • Market Cap
  • EDSA 15.9M
  • NVFY 18.8M
  • IPO Year
  • EDSA N/A
  • NVFY N/A
  • Fundamental
  • Price
  • EDSA $2.11
  • NVFY $1.82
  • Analyst Decision
  • EDSA Strong Buy
  • NVFY
  • Analyst Count
  • EDSA 2
  • NVFY 0
  • Target Price
  • EDSA $13.00
  • NVFY N/A
  • AVG Volume (30 Days)
  • EDSA 38.0K
  • NVFY 158.1K
  • Earning Date
  • EDSA 08-08-2025
  • NVFY 08-18-2025
  • Dividend Yield
  • EDSA N/A
  • NVFY N/A
  • EPS Growth
  • EDSA N/A
  • NVFY N/A
  • EPS
  • EDSA N/A
  • NVFY N/A
  • Revenue
  • EDSA N/A
  • NVFY $9,946,300.00
  • Revenue This Year
  • EDSA N/A
  • NVFY N/A
  • Revenue Next Year
  • EDSA N/A
  • NVFY N/A
  • P/E Ratio
  • EDSA N/A
  • NVFY N/A
  • Revenue Growth
  • EDSA N/A
  • NVFY N/A
  • 52 Week Low
  • EDSA $1.55
  • NVFY $0.39
  • 52 Week High
  • EDSA $5.18
  • NVFY $3.59
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 42.63
  • NVFY 42.54
  • Support Level
  • EDSA $2.02
  • NVFY $1.81
  • Resistance Level
  • EDSA $2.35
  • NVFY $2.86
  • Average True Range (ATR)
  • EDSA 0.14
  • NVFY 0.37
  • MACD
  • EDSA -0.03
  • NVFY -0.12
  • Stochastic Oscillator
  • EDSA 18.00
  • NVFY 0.79

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About NVFY Nova Lifestyle Inc.

Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.

Share on Social Networks: